OTC · Healthcare · Biotechnology
Hepion Pharmaceuticals, Inc.
HEPA
Hepion Pharmaceuticals, Inc. CEO Gary S. Stetz · Market cap $873K.
$0.07
+0.00 · +0.00%
52w hi $0.1152w lo $0.03
Off 52w high 53.6%
87
STRONG
Current InsiderScore
Corp · 90d
6
6 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
11
8 strong · 3 notable
Analyst consensus
Strong Buy
Avg PT $70.00
Section 01
Recent Form 4 filings
11 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 03 | Michael J. Purcell | Buy | 2,000,000 | $0.05 | +$100K | 75 | |
| Aug 03 | Vincent S Lopriore | Executive Chairman | Buy | 2,000,000 | $0.05 | +$100K | 77 |
| Aug 03 | Gary S. Stetz II | Buy | 500,000 | $0.05 | +$25K | 73 | |
| Aug 03 | Sireesh Appajosyula | Chief Operating Officer | Buy | 2,000,000 | $0.05 | +$100K | 81 |
| Aug 03 | Gary S. Stetz | Interim CEO | Buy | 2,000,000 | $0.05 | +$100K | 84 |
| Aug 03 | Vincent S Lopriore | Executive Chairman | Buy | 8,000,000 | $0.05 | +$400K | 87 |
| Apr 21 | Vincent S Lopriore | Executive Chairman | Buy | 5,000,000 | $0.04 | +$200K | 87 |
| Apr 21 | Gary S. Stetz | Interim CEO | Buy | 1,250,000 | $0.04 | +$50K | 82 |
| Apr 21 | Vincent S Lopriore | Executive Chairman | Buy | 1,250,000 | $0.04 | +$50K | 75 |
| Apr 21 | Sireesh Appajosyula | Buy | 1,250,000 | $0.04 | +$50K | 73 | |
| Apr 21 | Michael J. Purcell | Buy | 1,250,000 | $0.04 | +$50K | 73 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug